Amoxicillin is one of the most commonly prescribed antibiotics for respiratory complaints, but for typical acute bronchitis it provides almost no measurable benefit. A large Cochrane review pooling thousands of patients found no meaningful difference in clinical improvement between people who took antibiotics and those who took a placebo, with the treated group shaving less than half a day off their total cough duration on average.
What the Evidence Actually Shows
The most comprehensive look at this question comes from a Cochrane systematic review covering 17 trials and thousands of participants. Across 11 trials, people given antibiotics were no more likely to be rated as clinically improved than those on placebo. Antibiotics did produce a slight reduction in cough duration, but it amounted to roughly half a day shorter out of what is typically a one-to-three-week illness. Days spent feeling unwell dropped by a similarly small margin. At the same time, antibiotic-treated patients were about 20% more likely to experience side effects like diarrhea, nausea, or rash.
1PubMed Central. Antibiotics for acute bronchitisA large European trial published in The Lancet Infectious Diseases tested amoxicillin specifically against placebo in over 2,000 adults with acute lower respiratory tract infections. Neither the duration of “moderately bad or worse” symptoms nor overall symptom severity differed significantly between the amoxicillin group and placebo. Amoxicillin did reduce the chance of new or worsening symptoms, but the effect was small: you would need to treat 30 patients for one person to benefit.
2The Lancet Infectious Diseases. Amoxicillin for acute lower-respiratory-tract infection in primary care in Europe: a double-blind, randomised controlled trialA separate randomized trial looked at amoxicillin-clavulanate (a stronger formulation) head-to-head with ibuprofen and placebo in patients who had discolored sputum, the kind of symptom that often leads doctors to reach for an antibiotic. Even in this group, cough lasted about 11 days regardless of whether patients received the antibiotic or placebo, with no statistically significant differences in cough resolution.
3BMJ. Efficacy of anti-inflammatory or antibiotic treatment in patients with non-complicated acute bronchitis and discoloured sputum: randomised placebo controlled trialWhy Amoxicillin Rarely Helps
The most straightforward explanation is that acute bronchitis is overwhelmingly caused by viruses. Antibiotics kill bacteria, not viruses, so they simply have nothing useful to target in most cases. Even when researchers used advanced molecular testing on bronchitis patients, viruses like rhinovirus and coronavirus turned up in a large proportion of cases.
4PLOS ONE. Microorganisms Causing Community-Acquired Acute Bronchitis: The Role of Bacterial InfectionSome bacterial pathogens do show up in acute bronchitis, and this is where the picture gets a bit more complicated than “it’s always viral.” One study using multiplex PCR found bacteria in over 40% of acute bronchitis cases, with Haemophilus influenzae and Streptococcus pneumoniae being the most common. But finding bacteria in the airways does not necessarily mean those bacteria are causing the illness. Many of these organisms live in the upper respiratory tract normally, and their detection during a viral infection may reflect normal colonization rather than a true bacterial cause. The clinical trial data bear this out: even when bacteria are present, antibiotics still do not change outcomes much.
4PLOS ONE. Microorganisms Causing Community-Acquired Acute Bronchitis: The Role of Bacterial InfectionThere is also a class of “atypical” bacteria, particularly Chlamydia pneumoniae and Mycoplasma pneumoniae, that can cause bronchitis. These organisms showed up in a meaningful number of lower respiratory tract infections in community studies.
5Thorax. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the communityBut here is the catch: amoxicillin does not work against atypical bacteria at all. Standard beta-lactam antibiotics like amoxicillin are structurally incapable of killing these organisms. If your bronchitis actually is caused by Mycoplasma or Chlamydia pneumoniae, a macrolide antibiotic (like azithromycin) would be needed rather than amoxicillin.
6PubMed. Is there a role for antibiotics in the treatment of asthma?: involvement of atypical organismsWhat the Guidelines Say
Major medical organizations have been consistent on this point for over two decades. The American College of Physicians and the Centers for Disease Control and Prevention jointly advise that clinicians should not perform diagnostic testing or start antibiotics for bronchitis unless pneumonia is suspected.
7PubMed. Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and PreventionSeparate guideline statements have reinforced that routine antibiotic treatment of uncomplicated acute bronchitis is not recommended regardless of how long the cough has lasted.
8PubMed Central. Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: backgroundDespite these recommendations, research presented at major infectious disease conferences has found that the majority of patients who show up with acute bronchitis still walk out with an antibiotic prescription. The gap between what the evidence supports and what actually happens in the exam room remains wide, driven largely by patient expectations and time pressure during visits.
The Side Effects You Take On for Almost No Benefit
When antibiotics provide meaningful benefit, their side effects are a worthwhile trade-off. For bronchitis, that math does not work. A secondary analysis of the large European amoxicillin trial found that a significantly higher proportion of people in the amoxicillin group reported diarrhea, nausea, or rash compared with placebo. Diarrhea was the most common problem, and men were particularly prone to developing rashes on amoxicillin. The number needed to harm was around 24, meaning for roughly every 24 people treated, one experienced a side effect they would not have had on placebo.
9PubMed Central. Adverse Effects of Amoxicillin for Acute Lower Respiratory Tract Infection in Primary Care: Secondary and Subgroup Analysis of a Randomised Clinical TrialBeyond individual side effects, unnecessary antibiotic courses contribute to antimicrobial resistance, which is a slow-moving public health crisis. Each unnecessary prescription nudges bacteria toward developing resistance, making infections harder to treat for everyone down the line. Overuse also leads to more frequent return visits, more medicalization of what are essentially self-limiting conditions, and higher healthcare costs.
10PubMed Central. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problemWhen Antibiotics Actually Are Warranted
The blanket “no antibiotics” recommendation applies specifically to uncomplicated acute bronchitis in otherwise healthy people. Several scenarios genuinely do call for antibiotic treatment.
If your doctor suspects pneumonia rather than simple bronchitis, antibiotics are appropriate and potentially life-saving. The two conditions can look similar in the early stages, which is partly why guidelines emphasize that clinicians should evaluate for pneumonia before deciding against antibiotics. Fever, rapid breathing, abnormal lung sounds, and chest X-ray findings all help distinguish pneumonia from bronchitis.
Whooping cough (pertussis) is another exception. Adults with pertussis can present with what looks like a stubborn case of bronchitis, complete with weeks of coughing fits. Evidence-based guidelines recommend that patients with confirmed or probable pertussis receive a macrolide antibiotic. Early treatment within the first few weeks can reduce the severity of coughing episodes and, critically, prevent spread to others who may be more vulnerable.
11PubMed Central. Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelinesPeople with chronic lung disease face different considerations. Guidelines on acute lower respiratory tract infections take a more permissive stance on antibiotics when patients have relevant underlying conditions like COPD.
12Family Practice. Is co-morbidity taken into account in the antibiotic management of elderly patients with acute bronchitis and COPD exacerbations?In COPD exacerbations specifically, amoxicillin has a reasonable track record. A study of COPD patients experiencing flare-ups found that about 91% treated with amoxicillin were clinically cured, a rate statistically comparable to amoxicillin-clavulanate.
13PubMed Central. Efficacy of amoxycillin versus amoxycillin/clavulanate in exacerbations of chronic pulmonary obstructive disease in primary careWhy the Cough Lasts So Long
One of the biggest reasons people ask for antibiotics is that the cough from bronchitis hangs around much longer than they expect. Most people assume a cough should resolve within a week. In reality, post-infectious cough from bronchitis routinely lasts two to three weeks and sometimes longer. This lingering cough is not a sign that the infection is still active or that you need antibiotics. It results from residual inflammation, excessive mucus production, and temporarily heightened sensitivity of cough receptors in the airways. Except in the case of bacterial sinusitis or early pertussis, antibiotics play no role in treating this phase of the illness.
14PubMed. Postinfectious cough: ACCP evidence-based clinical practice guidelinesUnderstanding this timeline matters because it is the mismatch between expectations and reality that drives much of the demand for antibiotics. If you expect the cough to end in five days and it is still going strong at day ten, it feels like something must be wrong. But ten days of cough after acute bronchitis is squarely in the normal range.
The Yellow or Green Sputum Myth
One of the most persistent misconceptions is that discolored mucus, particularly yellow or green sputum, signals a bacterial infection requiring antibiotics. The randomized trial from BMJ that tested amoxicillin-clavulanate specifically enrolled patients with discolored sputum to address this exact belief. It found no benefit from the antibiotic compared with placebo even in these patients.
3BMJ. Efficacy of anti-inflammatory or antibiotic treatment in patients with non-complicated acute bronchitis and discoloured sputum: randomised placebo controlled trialThe color of sputum reflects immune cell activity, not necessarily bacterial infection. When your body fights any respiratory infection, viral or bacterial, white blood cells flood the airways. As these cells break down, enzymes containing iron give the mucus a greenish tint. It is a sign your immune system is working, not that you need an antibiotic.
What Actually Helps You Feel Better
If antibiotics are off the table for most bronchitis, what should you do while waiting out the illness? The honest answer is that no single remedy has been proven to dramatically shorten the course, but several options can take the edge off symptoms.
Honey has some of the better evidence behind it. A systematic review and meta-analysis found that honey reduced both cough frequency and cough severity compared with usual care in upper respiratory infections.
15PubMed. Effectiveness of honey for symptomatic relief in upper respiratory tract infections: a systematic review and meta-analysisIn children, Cochrane review evidence showed that honey was probably better than placebo and no treatment at reducing cough frequency, and performed about as well as dextromethorphan, one of the most common cough suppressant ingredients in pharmacy products. The benefit appeared most pronounced in the first three days.
16Cochrane Database of Systematic Reviews. Honey for acute cough in childrenHoney should not be given to children under one year of age due to botulism risk.
Over-the-counter cough medicines perform poorly in rigorous testing. A Cochrane review of oral cough preparations found that codeine was no better than placebo, and results for dextromethorphan were mixed. One larger trial found that patients felt guaifenesin (an expectorant) was helpful, but a second study found no significant differences from placebo.
17Cochrane Database of Systematic Reviews. Oral over-the-counter cough preparations for acute cough in children and adultsA separate evidence review concluded bluntly that there is no good evidence supporting commonly used over-the-counter cough medicines for acute cough.
18PubMed. There is no good evidence for the effectiveness of commonly used over-the-counter medicine to alleviate acute coughInhaled bronchodilators, the type of medicine in rescue inhalers, occasionally come up as a bronchitis treatment. One small trial found that patients given an albuterol inhaler were significantly less likely to still be coughing after a week compared to placebo users.
19PubMed. Albuterol delivered by metered-dose inhaler to treat acute bronchitisHowever, a broader Cochrane review combining multiple trials found no overall significant benefit from beta2-agonists in acute bronchitis. The trials that did see improvement were those where patients had wheezing at baseline, suggesting that bronchodilators may help if your bronchitis causes noticeable wheezing or airflow limitation, but are unlikely to help otherwise.
20Cochrane Database of Systematic Reviews. Beta2‐agonist drugs for acute bronchitisBeyond pharmacy options, staying hydrated, resting, and using steam or a humidifier to loosen mucus are low-risk comfort measures. None of these have been rigorously tested in large trials for acute bronchitis specifically, but they carry no downside and address the most bothersome symptoms directly.
The Delayed Prescription Approach
Some clinicians use a strategy called a delayed prescription. Rather than prescribing antibiotics immediately or refusing outright, the doctor writes a prescription but asks the patient to wait a set number of days before filling it, filling it only if symptoms worsen or fail to improve. A Cochrane review found that this approach dramatically reduced actual antibiotic use compared with immediate prescribing, while maintaining patient satisfaction at levels comparable to getting an immediate prescription.
21PubMed Central. Delayed antibiotic prescriptions for respiratory infectionsSurveys of primary care clinicians found that most believed delayed prescriptions reduced emergency visits, scheduled return visits, and inappropriate antibiotic use, and that patients were generally satisfied with the approach.
22PubMed Central. Use of delayed antibiotic prescription in primary care: a cross-sectional studyIf your doctor offers you a delayed prescription for bronchitis, it is worth understanding what the strategy is designed to do. Most bronchitis cases improve on their own within those waiting days, and the prescription ends up unnecessary. For the minority that worsen, the prescription is already in hand. It is a practical compromise in a medical encounter where both sides often feel pressure to “do something.”
Can a Blood Test Tell You Whether Antibiotics Would Help
Researchers have investigated whether biomarkers in the blood could help doctors distinguish bacterial bronchitis (where antibiotics might help) from viral bronchitis (where they will not). Procalcitonin, a protein that rises in bacterial infections but stays low in viral ones, has shown promise as such a marker. Studies have found that using procalcitonin levels to guide antibiotic decisions could reduce unnecessary prescriptions while identifying the patients who genuinely need treatment.
23PubMed Central. The role of procalcitonin as a guide for the diagnosis, prognosis, and decision of antibiotic therapy for lower respiratory tract infectionsIn practice, though, procalcitonin testing is not yet standard for outpatient bronchitis. It is used more often in hospitals, particularly in emergency departments and intensive care settings where the stakes of missing a bacterial infection are higher. For the typical primary care visit where you show up with a cough, your doctor is more likely to rely on your symptoms, a physical exam, and possibly a chest X-ray to rule out pneumonia than to order a blood test. Procalcitonin-guided prescribing may become more common as rapid testing becomes cheaper and more accessible, but for now it remains more of a research-supported concept than everyday practice for bronchitis specifically.